• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

饮食可通过翻译后修饰改变小鼠肠道微生物蛋白质组,从而调节肾功能。

Diet posttranslationally modifies the mouse gut microbial proteome to modulate renal function.

机构信息

Departments of Immunology and Infectious Diseases and Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.

Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.

出版信息

Science. 2020 Sep 18;369(6510):1518-1524. doi: 10.1126/science.abb3763.

DOI:10.1126/science.abb3763
PMID:32943527
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8178816/
Abstract

Associations between chronic kidney disease (CKD) and the gut microbiota have been postulated, yet questions remain about the underlying mechanisms. In humans, dietary protein increases gut bacterial production of hydrogen sulfide (HS), indole, and indoxyl sulfate. The latter are uremic toxins, and HS has diverse physiological functions, some of which are mediated by posttranslational modification. In a mouse model of CKD, we found that a high sulfur amino acid-containing diet resulted in posttranslationally modified microbial tryptophanase activity. This reduced uremic toxin-producing activity and ameliorated progression to CKD in the mice. Thus, diet can tune microbiota function to support healthy host physiology through posttranslational modification without altering microbial community composition.

摘要

已经有人提出,慢性肾脏病(CKD)与肠道微生物群之间存在关联,但关于潜在机制仍存在一些疑问。在人类中,饮食中的蛋白质会增加肠道细菌产生的硫化氢(HS)、吲哚和吲哚硫酸酯。后两者是尿毒症毒素,而 HS 具有多种生理功能,其中一些功能是通过翻译后修饰来介导的。在 CKD 的小鼠模型中,我们发现,含高硫氨基酸的饮食会导致翻译后修饰的微生物色氨酸酶活性。这降低了尿毒症毒素产生的活性,并改善了小鼠的 CKD 进展。因此,饮食可以通过翻译后修饰来调节微生物群的功能,以支持健康的宿主生理,而不改变微生物群落组成。

相似文献

1
Diet posttranslationally modifies the mouse gut microbial proteome to modulate renal function.饮食可通过翻译后修饰改变小鼠肠道微生物蛋白质组,从而调节肾功能。
Science. 2020 Sep 18;369(6510):1518-1524. doi: 10.1126/science.abb3763.
2
Modulation of a Circulating Uremic Solute via Rational Genetic Manipulation of the Gut Microbiota.通过对肠道微生物群进行合理的基因操作来调节循环中的尿毒症溶质。
Cell Host Microbe. 2016 Dec 14;20(6):709-715. doi: 10.1016/j.chom.2016.10.021. Epub 2016 Dec 1.
3
Targeting the gut microbial metabolic pathway with small molecules decreases uremic toxin production.靶向小分子的肠道微生物代谢途径可减少尿毒症毒素的产生。
Gut Microbes. 2020 Nov 9;12(1):1-19. doi: 10.1080/19490976.2020.1823800.
4
Microbial Modulation of a Uremic Toxin.尿毒症毒素的微生物调节。
Cell Host Microbe. 2016 Dec 14;20(6):691-692. doi: 10.1016/j.chom.2016.11.005.
5
Mechanism-based inhibition of gut microbial tryptophanases reduces serum indoxyl sulfate.基于机制的肠道微生物色氨酸酶抑制作用可降低血清吲哚硫酸酯。
Cell Chem Biol. 2023 Nov 16;30(11):1402-1413.e7. doi: 10.1016/j.chembiol.2023.07.015. Epub 2023 Aug 25.
6
Isolation and Quantification of Uremic Toxin Precursor-Generating Gut Bacteria in Chronic Kidney Disease Patients.慢性肾脏病患者中产生尿毒症毒素前体的肠道细菌的分离和定量。
Int J Mol Sci. 2020 Mar 14;21(6):1986. doi: 10.3390/ijms21061986.
7
Uremic Toxin-Producing Gut Microbiota in Rats with Chronic Kidney Disease.慢性肾病大鼠中产生尿毒症毒素的肠道微生物群
Nephron. 2017;135(1):51-60. doi: 10.1159/000450619. Epub 2016 Oct 5.
8
Diet-microbiota interaction and kidney disease progression.饮食与微生物群的相互作用及肾脏疾病进展
Kidney Int. 2021 Apr;99(4):797-800. doi: 10.1016/j.kint.2020.11.006. Epub 2020 Nov 24.
9
The Impact of CKD on Uremic Toxins and Gut Microbiota.慢性肾脏病对尿毒症毒素和肠道微生物群的影响。
Toxins (Basel). 2021 Mar 31;13(4):252. doi: 10.3390/toxins13040252.
10
Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease.在慢性肾脏病的不同阶段,肠道微生物群产生蛋白质结合型尿毒症毒素及相关代谢产物的情况并未改变。
Kidney Int. 2020 Jun;97(6):1230-1242. doi: 10.1016/j.kint.2020.01.028. Epub 2020 Feb 17.

引用本文的文献

1
Conjugation-based genetic manipulation of .基于共轭的……基因操作 (原文句子不完整,翻译可能不太准确,你可补充完整原文以便更准确翻译)
mBio. 2025 Jul 30:e0171425. doi: 10.1128/mbio.01714-25.
2
Microbiota and kidney disease: the road ahead.微生物群与肾脏疾病:未来之路
Nat Rev Nephrol. 2025 Oct;21(10):702-716. doi: 10.1038/s41581-025-00988-5. Epub 2025 Jul 28.
3
The alternations of gut microbiota in diabetic kidney disease: insights from a triple comparative cohort.糖尿病肾病中肠道微生物群的变化:来自三重比较队列的见解

本文引用的文献

1
Chronic Kidney Disease Diagnosis and Management: A Review.慢性肾脏病的诊断与管理:综述。
JAMA. 2019 Oct 1;322(13):1294-1304. doi: 10.1001/jama.2019.14745.
2
Burden, access, and disparities in kidney disease.肾脏疾病的负担、可及性及差异
Saudi J Kidney Dis Transpl. 2019 Mar-Apr;30(2):281-290. doi: 10.4103/1319-2442.256834.
3
Clostridium difficile Modulates the Gut Microbiota by Inducing the Production of Indole, an Interkingdom Signaling and Antimicrobial Molecule.艰难梭菌通过诱导吲哚(一种跨界信号传导和抗菌分子)的产生来调节肠道微生物群。
Front Cell Infect Microbiol. 2025 Jun 27;15:1606700. doi: 10.3389/fcimb.2025.1606700. eCollection 2025.
4
A specifically designed multi-biotic reduces uremic toxin generation and improves kidney function.一种专门设计的多种生物制剂可减少尿毒症毒素的产生并改善肾功能。
Gut Microbes. 2025 Dec;17(1):2531202. doi: 10.1080/19490976.2025.2531202. Epub 2025 Jul 12.
5
Associations of Dietary Protein Intake and Amino Acid Patterns with the Risk of Diabetic Kidney Disease in Adults with Type 2 Diabetes: A Cross-Sectional Study.2型糖尿病成年患者膳食蛋白质摄入量和氨基酸模式与糖尿病肾病风险的关联:一项横断面研究
Nutrients. 2025 Jun 29;17(13):2168. doi: 10.3390/nu17132168.
6
Field direction of static magnetic fields influences kidney fibrosis progression through MAPK signaling and cell cycle alteration.静磁场的场方向通过丝裂原活化蛋白激酶(MAPK)信号传导和细胞周期改变影响肾纤维化进展。
Sci Rep. 2025 Jul 10;15(1):24841. doi: 10.1038/s41598-025-09077-w.
7
Pediatric and adult point of view on the gut-kidney axis in CKD.儿童和成人对慢性肾脏病中肠-肾轴的观点。
Pediatr Nephrol. 2025 Jul 7. doi: 10.1007/s00467-025-06780-8.
8
Intestinal pH: a major driver of human gut microbiota composition and metabolism.肠道pH值:人类肠道微生物群组成和代谢的主要驱动因素。
Nat Rev Gastroenterol Hepatol. 2025 Jul 2. doi: 10.1038/s41575-025-01092-6.
9
Dietary carbohydrates alter immune-modulatory functionalities and DNA inversions in Bacteroides thetaiotaomicron.膳食碳水化合物会改变嗜热栖热放线菌的免疫调节功能和DNA倒位。
Nat Commun. 2025 May 28;16(1):4938. doi: 10.1038/s41467-025-60202-9.
10
Translocation of gut bacteria promotes tumor-associated mortality by inducing immune-activated renal damage.肠道细菌易位通过诱导免疫激活的肾损伤促进肿瘤相关死亡。
EMBO J. 2025 May 22. doi: 10.1038/s44318-025-00458-5.
mSystems. 2019 Mar 19;4(2). doi: 10.1128/mSystems.00346-18. eCollection 2019 Mar-Apr.
4
Diet, gut microbiome and indoxyl sulphate in chronic kidney disease patients.慢性肾病患者的饮食、肠道微生物群与硫酸吲哚酚
Nephrology (Carlton). 2018 Oct;23 Suppl 4:16-20. doi: 10.1111/nep.13452.
5
Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.对慢性肾脏病的影响以及 AST-120 的缓解作用。
Toxins (Basel). 2018 Sep 11;10(9):367. doi: 10.3390/toxins10090367.
6
Endpoint or Kinetic Measurement of Hydrogen Sulfide Production Capacity in Tissue Extracts.组织提取物中硫化氢生成能力的终点或动力学测量。
Bio Protoc. 2017 Jul 5;7(13). doi: 10.21769/BioProtoc.2382.
7
Dietary methionine restriction modulates renal response and attenuates kidney injury in mice.限制饮食蛋氨酸可调节肾脏反应并减轻小鼠的肾脏损伤。
FASEB J. 2018 Feb;32(2):693-702. doi: 10.1096/fj.201700419R. Epub 2018 Jan 4.
8
Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients.肾功能受损和肠道微生物群落失调导致慢性肾脏病患者中三甲胺-N-氧化物水平升高。
Sci Rep. 2017 May 3;7(1):1445. doi: 10.1038/s41598-017-01387-y.
9
Indoxyl Sulfate-Review of Toxicity and Therapeutic Strategies.硫酸吲哚酚——毒性与治疗策略综述
Toxins (Basel). 2016 Nov 30;8(12):358. doi: 10.3390/toxins8120358.
10
Modulation of a Circulating Uremic Solute via Rational Genetic Manipulation of the Gut Microbiota.通过对肠道微生物群进行合理的基因操作来调节循环中的尿毒症溶质。
Cell Host Microbe. 2016 Dec 14;20(6):709-715. doi: 10.1016/j.chom.2016.10.021. Epub 2016 Dec 1.